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Abstract
Interferon (IFN)-c release assays (IGRA) have improved tuberculosis contact tracing, but discrimination of recent from
remote Mycobacterium tuberculosis contacts is not possible by IGRA alone. We present results of a tuberculosis contact
investigation with a new early-secretory-antigenic-target (ESAT)-6 and culture-filtrate-protein (CFP)-10 specific interleukin
(IL)-2 ELISpot in addition to ESAT-6 and CFP-10 specific IFN-c ELISpot and tuberculin skin testing (TST). Results of the TST,
IFN-c ELISpot and IL-2 ELISpot were positive in 6/172 (3.4%), 7/167 (4.2%) and 6/196 (3.1%) of contacts, respectively. Close
contact ($100 hours) to the index case increased the risk of positive results in the IFN-c ELISpot, TST, and IL-2 ELISpot by
40.8, 19.3, and 2.5 times, respectively. Individuals with a positive IFN-c ELISpot/negative IL-2 ELISpot result had a median
(IQR) duration of index case exposure of 568 hours (133_1000) compared to individuals with a positive IFN-c ELISpot/
positive IL-2 ELISpot result (median=24 hours; 20_130; p-value=0.047). Combination of a M. tuberculosis specific IFN-c
ELISpot with a M. tuberculosis specific IL-2 ELISpot significantly improved the identification of individuals with the highest
risk of recent M. tuberculosis infection and is a promising method that should be explored to target tuberculosis preventive
chemotherapy.
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Introduction
Identification and treatment of individuals with lasting
Mycobacterium tuberculosis specific immune responses (latent
tuberculosis infection -, LTBI) following recent contact to a
contagious index case with pulmonary tuberculosis are crucial to
tuberculosis control [1]. The diagnosis and management of
LTBI has evolved over the last decade with improvements in the
immunodiagnosis by M. tuberculosis specific interferon-c release
assays (IGRA) in addition to the tuberculin skin test [2]. In
principle, IGRA detect interferon-c release by mononuclear
cells in the ELISpot (T-SPOT.TB –O x f o r dI m m u n o t e c ,
Abingdon, UK) or in whole blood in the ELISA (Quanti-
FERON-TB GOLD in tube; QFT-G-IT; Cellestis, Carnegie,
Australia) following ex vivo contact with antigens that are
naturally encoded in the M. tuberculosis genomic region of
difference (RD)-1 and RD11 (only QFT-G-IT). The genes
encoding for these proteins are not present in most non
tuberculous mycobacteria and are deleted from the genome of
M. bovis Bacille Calmette Guerin (BCG) strains that are used for
tuberculosis vaccinations [3,4]. The population of T lympho-
cytes responding rapidly with the production of IFN-c following
ex vivo stimulation with these antigens belongs predominantly to
the pool of CD4+ CD45RA-CCR7- effector memory cells that
likely had recent antigen exposure [5]. In contrast, long-lived
central memory T-cells may persist even after successful
treatment of tuberculosis [6,7] and are less likely to release
IFN-c after short incubation with antigen while they are more
likely to produce IL-2 upon antigen exposure than effector cells
[7]. Thus, assaying M. tuberculosis-specific T cell function defined
solely by the quantification of IFN-c secretion after short term ex
vivo incubation with M. tuberculosis-specific antigen may prove to
be an insufficient indicator for recent inhalation exposure to M.
tuberculosis. In contrast, simultaneous measures of other T cell
function, such as M. tuberculosis-specific stimulation of IL-2
secretion may improve the discrimination of active versus
remote LTBI [7].
A 28-year-old schoolteacher was referred to our hospital for
diagnostic evaluations for presumptive tuberculosis. Between
March and October 2007 he had consulted seven different
general practitioners complaining of progressive cough and weight
loss until finally in November 2007 a chest x-ray was performed
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11670and a cavitating lesion in the left upper lobe of the lung was
demonstrated.
In our hospital, alcohol acid fast bacilli (AAFB) were readily
identified on sputum smears. The bacilli were identified as M.
tuberculosis by culture and susceptibility testing revealed antibiotic
drug resistance to isoniacid and streptomycin. We estimated by the
presence of his symptoms that he had been infectious for a period
of seven months prior to hospital admission. During this period, he
had exposure to a large number of close contacts including pupils
and teachers from two different schools and members of a church
parish.
We describe the results of tuberculosis contact tracing among
well-defined contacts of a highly symptomatic sputum smear
positive index case, comparing a novel M. tuberculosis antigen
specific IL-2 ELISpot assay with a M. tuberculosis antigen specific
IFN-c ELISpot and the TST for the diagnosis of LTBI. This
outbreak provided an opportunity to test the hypothesis that
simultaneous measures of M. tuberculosis-specific IFN-c and IL-2
secretion may improve identification of individuals with the
highest risk of recent infection with M. tuberculosis.
Materials and Methods
Study population
Individuals with close contact to the symptomatic index case
during the period of March 2007 until October 2007 were
identified by the municipal health care department of the city of
Luebeck, Germany.
Contacts were asked to estimate their exposure time to the index
case in hours per week. We identified a group of close (with a total
exposure of 100 hours or more) and another of occasional contacts
(exposure of less than 100 hours). For 76 contacts who did not
provide any information about exposure to the index case, the
time was estimated according to the average exposure of
classmates. In addition information about BCG vaccination status,
possible former contact to tuberculosis, and pre-existing illness and
medication were obtained. Data were recorded on a standardized
questionnaire.
All adults and children who were enrolled agreed by written
informed consent to participate in the study. In addition, the
agreement of both legal guardians was obtained for the children
who were enrolled. The study was approved by the ethical
committee of the University of Luebeck, Germany.
Tuberculin skin test (TST)
Tuberculin skin testing was performed by intracutaneous
injection of 2U/0.1ml of tuberculin RT23 (Statens Serum Institut,
Copenhagen, Denmark) on the volar aspect of the forearm. The
TST was administered and read by experienced staff from the
Municipal Health Authority. Indurations were measured at 48–
72 hours by two independent readers [8]. Parallel to TST testing
blood was taken from contacts after informed consent following an
eight week period after the last exposure to the index case [9].
Chest radiographs of the TST-positive contacts were performed,
and clinical and radiographic findings were reviewed for evidence
of active tuberculosis.
ELISpot assay
ELISpot assays for IFN-c and separately for IL-2 release by
mononuclear cells were performed using test-plates from AID,
Strassberg, Germany. Briefly, 250,000 PBMCs were plated
overnight on 96-well plates, which had been pre-coated with a
mouse anti-human IFN-c or IL-2 antibody, in 200 ml culture
medium per well. The cells were left unstimulated (negative
control), were stimulated with 10 ng/ml anti-CD3 monoclonal
antibody (clone X35, Beckman-Coulter, Krefeld, Germany;
positive control) and with 5 mg/ml of ESAT-6 and CFP-10
peptides (kindly provided by AID, Strassberg, Germany). Culture
of the plates, washing, counterstaining, visualisation and analysis of
the spots was performed according to the manufacturer guidelines.
The response of stimulated cultures was considered positive
when the test well contained .5 spots and had at least twice the
number of spots than the negative control well. The background
number of spots in negative control wells was always less than five
spots per well. The response of stimulated cultures was considered
negative when the test well contained #5 spots or less than twice
the number of spots in the unstimulated control well and when the
positive control well contained at least 50 spots at the same time.
Analysis of host activating potential of the index cases M.
tuberculosis strain
Human THP1 cells were differentiated for 96h in the presence
of 5 ng/ml PMA. Human monocyte-derived macrophages
(MDM) were generated as previously described [10]. Mycobacterium
tuberculosis strains H37Rv (ATCC 27294) and the index cases M.
tuberculosis strain (9729/07) were grown at 37uC in Middlebrook
7H9 broth supplemented with Middlebrook OADC-Enrichment
(BD Biosciences) to an OD of 0.2–0.4. Cultures were harvested,
aliquoted, and frozen at 280uC. Viable cell counts were
determined by plating serial dilutions of cultures on Middlebrook
7H10 agar plates (BD Biosciences). For experimental in vitro
infections, aliquots were diluted in culture media and the
preparation was passed six times through a 27-gauge needle to
ensure proper dispersion of mycobacteria.
THP-1 (3610
5/ml) cells and MDM (5610
5) cells were
stimulated in 500 ml cultures for 4h in the absence or presence
of Mtb strains H37Rv or 9729/07 at the indicated multiplicity of
infection (MOI). Bacterial lipopolysaccharide (LPS) of Salmonella
enterica, serotype friedenau H909, was kindly provided by Prof. Dr.
H. Brade (Research Center Borstel, Borstel, Germany) and used as
positive control. Supernatants were frozen at 280uC until analysis.
The formation of TNF-a was analyzed by ELISA (TNF Duoset,
R&D Systems), as recommended by the manufacturer.
Statistical analysis
Data were analysed using Stata 9.0 (StataCorp, Stata Statistical
Software Release 9, College Station, TX, USA, 2005). Categorical
data were compared using the Chi-squared test (or Fisher’s exact
test, when expected cell sizes were smaller than five). The
Wilcoxon-Mann-Whitney test was used for continuous measure-
ments to test relationships in unpaired analysis, when assumed that
the dependent variable is a not normally distributed interval
variable. Since there is no gold standard for the determination of
LTBI, the analysis was focussed on estimating the strength of
association between the degree of exposure (the duration and
proximity of contact with the infectious case) and the test results.
Logistic regression analysis was performed in order to evaluate
which covariates have had an association with a positive test result.
Test concordance was assessed by Cohen’s k-statistics with
agreement considered slight’for k#0.2, ‘fair’ for 0.2,k#0.4,
‘moderate’for 0.4,k#0.6, ‘substantial’for 0.6,k#0.8 and ‘opti-
mal’for 0.8,k#1.0. A Spearman correlation was used in order to
evaluate the relationship between two variables (contacts’ hours of
exposure with IFN-c or IL-2 ELISpot test results, respectively),
assumed to be not normally distributed and interval. The tests
were performed as two-sided tests. Test results were regarded to be
statistical significant if the p-value was ,0.05.
TB Contact Tracing
PLoS ONE | www.plosone.org 2 July 2010 | Volume 5 | Issue 7 | e11670Results
Among the 274 close contacts were the index patient’s family
and close friends, members of his church community including the
church music group, where he participated as guitarist, colleagues
and staff from the two schools where he worked as a teacher,
students from seven different school classes, and a guitar student.
The patterns of exposure are shown in figure 1.
Tuberculin skin test
A total of 172 (62.7%) of 274 contacts were tested with the TST.
Only six (3.4%) out of 172 developed a TST induration of $5m m
which is regarded as a positive test result in recent contacts
according to national guidelines in Germany [9].
Eighteen of 172 (10.5%) contacts reported a history of BCG-
vaccination. Three of these 18 individuals (16.7%) had a positive
TST result. Seventy-four (43.0%) individuals reported that they
had not been vaccinated with BCG. In this group, 1/74 (1.4%)
had a positive TST result. In the remaining 80 individuals, mostly
school children, the BCG vaccination status was unclear. In this
group 2/80 (2.5%) had a positive TST result.
ELISpot assays
One hundred ninety-six of 274 (71.5%) were tested with IL-2
ELISpot while only 167/274 (60.9%) contacts were tested with
IFN-c ELISpot (figure 2).
In 34 cases the volume of blood sampled was insufficient to
perform both assays. Since for our study IL-2 ELISpot testing was
more interesting we generally performed IL-2 readout first when
the amount of blood was insufficient for both assays. In 33 of 34
cases we also performed additional skin testing, one contact later
received ELISA testing by the city’s health authorities (Quanti-
FERON-TB Gold). All these 34 cases were negative on IL-2 testing
and also on additional TST or ELISA, respectively.
In five other cases we performed IFN-c ELISpot without IL-2
readout, three of these contacts were also tested with TST
(figure 2). In these five cases the contacts or their parents had
only agreed on testing with methods already approved by the
German national guidelines. All five contacts showed negative
IFN-c ELISpot results, the TST were also negative.
IL-2 ELISpot assay
In 6/196 (3.1%) the test IL-2 ELISpot assay result was positive.
Among these six contacts three had been positive on IFN-c
ELISpot testing while three had been negative. The positive test
results are summarized in table 1.
Among the six contacts tested positive on IL-2 ELISpot was a
51 year-old female teacher who reported intensive tuberculosis
contact more than 20 years ago. She did not receive antituber-
culosis preventive chemotherapy despite having a positive TST
reaction at that time. In her case the net numbers of the IL-2
specific spots (11 in the CFP-10 ELISpot, 10 with ESAT-6) were
highest among all contacts. Her IFN-c ELISpot result was also
positive. A TST had not been performed, and her vaccination
status was unknown. This woman’s exposure to the index case was
quantified as 24 contact hours.
Among those three contacts tested positive on IL-2 ELISpot
while being negative on IFN-c ELISpot were two contacts, a
student and a teacher, with negative TST results. One had not
been vaccinated; the other’s BCG status was unknown. Their time
of exposure was 32 and 48 hours, respectively. The third one, a
14-year-old boy, had not received skin testing. He had not been
vaccinated. His time of exposure was 32 hours.
IFN-c ELISpot assay
In 7/167 (4.2%), the test results with the IFN-c ELISpot were
positive. In 156 cases, the IFN-c ELISpot test results were
negative, and in four cases (2.4%) the test results were
indeterminate. In these 4 contacts TST could not be performed.
In such cases the city’s health authorities performed mandatory
Figure 1. Pattern of exposure among 274 contacts of a teacher
with sputum acid fast bacilli smear-positive pulmonary
tuberculosis.
doi:10.1371/journal.pone.0011670.g001
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D In these 17 cases a
skin test could not be performed. Because we did not obtain their informed consent for participation, these individuals were not tested with ELISpot
in the study but tested by the city’s health authorities with ELISA (QuantiFERON-TB Gold). $ These 2 contacts did not receive IL-2 ELISpot testing
because they had only agreed on testing with test methods already approved by the health authorities. We performed IFN-c ELISpot here. 1 In this
case the amount of blood taken from the student was not sufficient to perform both ELISpot tests. This contact later received ELISA testing from the
city’s health authorities, in which she showed a negative result. * These 3 contacts or their parents did not agree on IL-2 ELISpot testing but only on
test methods already approved by the health authorities.
# These 4 contacts showed an indeterminate IFN-c ELISpot result. Because skin testing
could not be performed, the city’s health authorities then tested these 4 with ELISA, in which all of them showed a negative result.
doi:10.1371/journal.pone.0011670.g002
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test result in the QFT-G-IT. The distribution of test results is
shown in figure 2.
All six TST-positive contacts were also tested by IFN-c
ELISpot. Two (33.3%) of them had a positive IFN-c ELISpot
result, four (66.7%) showed a negative IFN-c ELISpot result. The
positive test results are summarized in table 1.
Influence of exposure time on test results
The median, Inter-Quartile Range –IQR-, time of exposure
to the index case was much higher among the contacts that
were positive on IFN-c ELISpot testing (130, 24_1000, hours)
than among those positive on IL-2 ELISpot (32, 24_48, hours),
but the difference was not statistically significant (p-
value=0.15).
For TST positive contacts the median (IQR) time of exposure
was 66 (56 _136) hours.
No statistically significant difference was found when the
median time of exposure among the contacts who were notified
as TST positive was compared to that of those with a positive IFN-
c result (p-value=0.52) or a positive IL-2 ELISpot result (p-
value=0.15).
Individuals with a positive IFN-c results and a negative IL-2
ELISpot result had a median (IQR) duration of exposure to the
index case of 568 hours (133_1000) compared to individuals with
a positive IFN-c results and a positive IL-2 ELISpot result with a
median (IQR) duration of exposure to the index case of 24 hours
(20_130; p-value=0.047) or individuals with a negative IFN-c
results and a positive IL-2 ELISpot result with a median (IQR)
duration of exposure to the index case of 32 hours (32_48; p-
value=0.031) (figure 3).
Logistic regression analysis of the association of a positive test
(IL-2 ELISpot assay, IFN-c IGRA and TST) with potential
explanatory covariates for diagnosis of LTBI was performed
(Table 2). Only when the independent variable ‘‘close contact’’
(i.e. exposure time $100 hours) was associated to the positive
result of IFN-c IGRA, highly statistically significant odds ratios
Table 1. Contacts with positive result in at least one of the immunodiagnostic tests.
Contact
number TST result
IFN-c ELISpot
result
IL-2 ELISpot
result BCG vaccination
Duration of
exposure (total
hours) Age (years)
Country of
birth
Former TB
contact
51 pos. neg. neg. yes 60 35 Germany no
224 pos. neg. neg. not known 56 12 unknown not known
247 pos. neg. neg. yes 72 31 Germany no
255 pos. neg. neg. no 12 39 Germany no
276 pos. pos. neg. yes 1000 56 Germany no
282 pos. pos. neg. not known 136 32 Germany yes
261 not tested pos. neg. no 130 43 Germany no
278 not tested pos. neg. yes 1000 58 Germany no
127 not tested pos. pos. not known 24 51 Germany yes
258 not tested pos. pos. yes 130 39 Germany no
216 neg. pos. pos. no 20 13 Germany no
252 neg. neg. pos. no 32 15 Germany no
43 neg. neg. pos. not known 48 45 Germany no
85 not tested neg. pos. no 32 14 Germany no
TST: Tuberculin skin test; ELISpot: enzyme-linked immunospot; BCG: Bacille Calmette-Gue ´rin.
doi:10.1371/journal.pone.0011670.t001
Figure 3. Results of M. tuberculosis specific enzyme linked
immunospot (ELISpot), assaying interferon (IFN)- c and
interleukin (IL)-2 production in response to ex vivo contact of
peripheral blood mononuclear cells with early antigenic target
(ESAT)-6 and culture filtrate protein (CFP)-10 in relation to the
cumulative time of exposure to an infectious index case.
* Differences are statistically significant.
doi:10.1371/journal.pone.0011670.g003
TB Contact Tracing
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value,0.0001) and multivariate analysis (27.9, 95%CI 4.2_183.5;
p-value=0.001); other statistically significant ORs obtained in the
univariate analysis and associated to covariates, like age with TST,
age with IFN-c IGRA and close contact with TST, were not
confirmed by a multi-variable model (table 2).
Agreement between TST and IFN-c ELISpot results and
between IFN-c ELISpot and IL2 ELISpot results was moderate
(kappa=0.42 and 0.44, respectively) while it was poor between
TST and IL2 ELISpot results (table 3).
Genotyping and analysis of TNF formation by the M.
tuberculosis strain of the index case ex vivo
The M. tuberculosis strain of the index case and the laboratory
strain H37Rv were genotyped as described previously [11].
MIRU-VNTR identified the strain of the index case to be of an
East African Indian genotype, whereas the laboratory reference
strain H37Rv was typed to belong to the Haarlem subtype. The
cytokine release of macrophages and dendritic cells to infection
with a given M. tuberculosis isolate is critical to induce a successful
induction of the antimycobacterial response of the host.
Table 2. Logistic regression analysis of the association of a positive interleukin (IL)-2 ELISpot assay, interferon (INF)-c ELISpot assay
and tuberculin skin test with potential explanatory factors for the presence of positive results in tests for the immunodiagnosis of
tuberculosis.
Covariates IL-2 ELISpot assay INF-c ELISpot assay Tuberculin skin test
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Exposure $100 hours 2.5
(0.3 23.0)
p,0.001)
1.7
(0.2 18.0)
p=0.6
40.8
(6.9 240.3)
p,0.001
27.9
(4.2 183.5)
p=0.001
19.3
(2.7 137.5)
p=0.003
8.5
(0.9 81.6)
p=0.06
BCG vaccination 1.4
(0.5 3.4)
p=0.51
1.2
(0.4 3.2)
p=0.72
1.7
(0.7 4.0)
p=0.21
1.36
(0.4 4.4)
p=0.6
2.3
(0.9 5.9)
p=0.07)
2.3
(0.7 7.3)
p=0.15
Age, years 1.02
(1.0 1.1)
p=0.3
1.02
(1.0 1.1)
p=0.44
1.06
(1.0 1.1)
p=0.008)
1.06
(1.0 1.13)
p=0.07
1.05
(1.0 1.1)
p=0.02
1.05
(1.0 1.1)
p=0.05)
Sex, male 0.8
(0.1 4.5)
p=0.8
0.8
(0.1 4.5)
p=0.8
1.1
(0.2 5.1)
p=0.9
0.8
(0.1 4.8)
p=0.72
1.05
(0.3 2.5)
p=0.29
0.37
(0.1 4.05)
p=0.41
*OR, odds ratio; CI, confidence interval.; BCG, Bacillus Calmette-Gue ´rin.
doi:10.1371/journal.pone.0011670.t002
Table 3. Inter reliability of diagnostic methods for the diagnosis of lasting immune responses to M. tuberculosis.
Diagnostic test Diagnostic test Cohen’s kappa (SE) Agreement*
IFN-c release ELISpot
Positive Negative Total
TST Positive 2 460 . 4 2
(0.1)
Moderate
Negative 17 6 7 7
Total 38 0 8 3
Tuberculin Skin Test
Positive Negative Total
IL-2 release
ELISpot
Positive 03 3 20.04
(0.1)
Less than chance
Negative 6 104 110
Total 6 107 113
IFN-c release ELISpot
Positive Negative Total
IL-2 release
ELISpot
Positive 3 360 . 4 4
(0.1)
Moderate
Negative 4 148 152
Total 7 151 158
*Criteria based on the interpretation of Landis and Koch are used.
doi:10.1371/journal.pone.0011670.t003
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cells and human monocyte-derived macrophages in response to
the M. tuberculosis strain of the index case and compared it to the
laboratory strain H37Rv. In figure 4 it is shown that the M.
tuberculosis strain of the index case lead to a 30–50% reduced TNF
formation compared to the lab strain H37Rv.
Discussion
In this tuberculosis contact investigation with a highly
symptomatic index case we performed TST and ELISpot testing
with both IFN-c and IL2 readouts among a large group of
asymptomatic close contacts.
Three important results emerged from this study: 1.) Despite a
high level of exposure among a large group of contacts, less than
5% had a positive IGRA response post exposure indicating
possible M. tuberculosis infection. None of the contacts developed
active tuberculosis. 2.) Ex vivo infection of monocytes and
macrophages with the M. tuberculosis strain of the index case
showed a significant reduction in the capacity to induce TNF
when compared to the laboratory strain H37Rv, related to the
attenuated virulence of this strain. 3.) Despite the low number of
individuals with LTBI in this cohort, the combination of IFN-c
and IL2 ELISpot allowed for a significantly better discrimination
of the level of exposure to the index case than IGRA alone.
With the introduction of IGRAs important advances have been
achieved in the immunodiagnosis of LTBI [12] and active
tuberculosis [13,14]. However, when IGRA are performed on
cells from the peripheral blood alone, they cannot discriminate
individuals with active tuberculosis from those with LTBI [15]. In
addition, in individuals with LTBI, IGRAs are not able to identify
those with recently acquired infection, who have the highest risk of
progression to active tuberculosis [16,17].
A potential method to improve the ability of IGRA to identify
individuals with recently acquired LTBI is a M. tuberculosis specific
IL2 release assay in addition to the IGRA. Interleukin-2 is
promoting T cell replication and is essential for cellular immunity
and granuloma formation. While IFN-c is predominantly
produced by effector memory T cells, IL-2 is predominantly
produced by central memory T cells. Recently, a shift in the IFN-c
and IL-2 cytokine profile from a codominance of IFN-c-only and
IFN-c/IL-2-secreting T cells and the appearance of IL-2-only
secreting T-cells during and after treatment of tuberculosis has
been demonstrated [18].
With increasing level of exposure to the index case, the chance
of a positive IFN-c ELISpot test increased by more than 40 times
while the risk of a positive IL-2 ELISpot increased only by 2.5
times in this study. Individuals with a positive IFN-c ELISpot
result and a negative IL-2 ELISpot result had the highest
cumulative duration of exposure to the index case and therefore
the highest chance of recent contact to M. tuberculosis. In contrast, a
positive result of the M. tuberculosis specific IL-2 ELISpot was not
significantly related to a higher exposure to the index case. In
agreement with previous longitudinal observations of IFN-c and
IL2 specific immune responses in patients with active tuberculosis
undergoing antituberculosis treatment [7] the additional IL-2
ELISpot did significantly improve the discrimination of putative
recent from remote infection with M. tuberculosis in our cohort.
Airborne transmission of M. tuberculosis is more likely when
duration and proximity of contact with an infectious case increase
[19,20]. The minimum amount of exposure that results in
infection and the time of exposure that makes M. tuberculosis
transmission inevitable remain unknown. In our study the index
case had probably been infectious for a period of seven months.
However, none of the contacts developed active tuberculosis. This
is a lower rate compared to other school outbreaks (e.g. in [21],
where in a group of 535 contacts nine secondary cases occurred
out of 97 cases with LTBI).
Well-documented cases of infection resulting from brief
exposure have been published [22]. Ewer et al. found in a British
school outbreak [21] ‘‘…that 130 hours sharing room air with a
person with sputum smear positive cavitatory tuberculosis is
certain to result in infection’’. However, in our study we found that
among those tested negative with all three test methods were also
contacts with up to 240hours of exposure, suggesting that the
degree of airborne M. tuberculosis transmission and/or the
infectiousness of patients with sputum AFB smear-positive
cavitatory tuberculosis can be very variable.
Despite the fact that the index case needed to be considered to
be highly contagious by the presence of large numbers of acid fast
bacilli on sputum smears we observed a positive IGRA response
post exposure in less than 5% of close contacts indicating possible
M. tuberculosis infection. To evaluate the possibility of an attenuated
virulence of this strain of M. tuberculosis, we consequently
Figure 4. TNF-a production of A) human THP-1 cells and of B) human monocyte-derived macrophages (MDM) in response to the M.
tuberculosis strain of the index case (9729/07) and the laboratory strain H37Rv. PMA-differentiated human THP-1 cells and MDM were
incubated with indicated multiplicities of infection (MOI) of viable M. tuberculosis. Supernatants were harvested 24 h after infection and TNF levels
were determined by ELISA. Data from one representative experiment of three are shown (LPS: lipopolysacharide; ctrl.: medium control, n.d.: not
detectable).
doi:10.1371/journal.pone.0011670.g004
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1 cells and monocyte derived macrophages with this strain and an
H37Rv reference strain of M. tuberculosis.
Genetic diversity of M. tuberculosis isolates may have implications
for the outcome of the disease. In a murine model of experimental
tuberculosis infection it was reported that genetically different M.
tuberculosis strains evoked markedly different immunopathological
events [23]. Bacteria with the Beijing genotype, highly prevalent in
Asia and Southern Africa, elicited a non-protective immune
response in mice and were the most virulent. The cytokine Tumor
necrosis factor (TNF) is essential for the development of protective
immunity against M. tuberculosis infection [24]. Granuloma
formation and granuloma maintenance are critically dependant
on the presence of TNF [25,26]. This has been demonstrated in
different experimental settings, including anti-TNF antibody
treatment, TNFRp55 deficiency and TNF-deficiency (reviewed
in [27]). Systemically reduced TNF levels, e.g. in the presence of
TNF targeted biologicals have been shown to significantly enhance
the risk of reactivation of tuberculosis [28,29,30] in latently
infected individuals. However in in vitro settings the role of TNF
may be more complex than previously expected in particular when
human immune cells are analyzed: We found a significant
reduction in the ability to induce TNF in human monocytes and
macrophages following ex vivo infection with the M. tuberculosis
strain of the index case, when compared to the virulent laboratory
strain H37Rv. Of interest in a similar study it has been shown that
infection of human alveolar macrophages with virulent M.
tuberculosis strains in vitro induced the secretion of significantly
higher levels of bioactive TNF than attenuated strains correlating
with their ability to multiply intracellularly [31]. In addition
treatment of infected human macrophages with neutralizing anti-
TNF antibodies reduced the growth rate of intracellular bacteria,
whereas bacterial replication was augmented by addition of
exogenous TNF [31]. Similar results have also been obtained with
human monocytes [32]. Tumor necrosis factor promotes growth
of virulent Mycobacterium tuberculosis in human monocytes iron-
mediated growth suppression is correlated with decreased release
of TNF from iron-treated infected monocytes]and also human
dendritic cells [33]. Inverse correlation of maturity and antibac-
terial activity in human dendritic cells. Based on these findings,
one is tempted to speculate that the low TNF release by the strain
of the index case may be related to a reduced virulence and a
relatively low transmission rate of this particular strain among
contacts. However this analysis was merely exploratory. A more
detailed analysis integrating a wide array of clinical isolates needs
to be done in order to accurately type the strain with respect to
strain-specific immune responses.
Several limitations of our study need to be addressed. As this
was an ad hoc outbreak evaluation with a predominant population
of children, not all contacts participated in the study and not all
tests for the immunodiagnosis of tuberculosis could be performed
in all contacts in parallel. Also, because of the relative low
frequency of positive IGRA responses among close contacts,
conclusions about exposure time and test results as well as the
added value of IL-2 ELISpot cannot be definitive and need to be
confirmed in similar outbreaks with a higher number of
individuals with positive IGRA responses. Due to low number of
cases possibilities of statistical processing of TST positive and IFN-
c and IL-2 ELISpot negative cases are limited.
This current study provides no conclusive evidence, but
contains some intriguing observations that, following ex vivo
contact with M. tuberculosis specific antigens, recently acquainted
infection with M. tuberculosis is related to a positive IFN-c ELISpot
and a negative IL-2 ELISpot while remote infection with M.
tuberculosis is related to a positive IFN-c ELISpot and a positive IL-
2 ELISpot. Longitudinal studies with larger numbers of contacts
with positive M. tuberculosis-specific immune responses will be
needed for a further exploration and clarification of this
hypothesis. Finally, a causative relation between the observed ex
vivo augmentation of TNF induction in monocytes and macro-
phages and the in vivo reduced transmission rate of this strain of M.
tuberculosis has not been established.
Conclusion
Despite intense contact to a highly symptomatic AFB-smear
positive index case, transmission of M. tuberculosis only rarely
occurred in this tuberculosis outbreak possibly related to
attenuated virulence of this strain.
Combination of a M. tuberculosis specific IFN-c ELISpot with a
M. tuberculosis specific IL-2 ELISpot improved the identification of
individuals with the highest risk of recent M. tuberculosis infection
and is a promising tool for the discrimination of recent from
remote LTBI that should be further explored.
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